This specific disease begins as a small papule, as shown above. Also, sepsis with gram-positive rods is identified in blood or cerebrospinal fluid. The size is 1m X 2m a rod.
This disease attacks a victim by first getting into their system by being inhaled, or transferred by blood. With Cutaneous anthrax, it enlarges and progresses to a vesicle in 1-2 days. Sometimes the vesicles tend to become hemorrhagic. Then the lesion ulcerates and becomes a necrotic ulcer in 3-7 days. This usually goes along unnoticed by the victim. The victim may initially experience Fever, Malaise, Headache, or Regional lymphadenopathy. With Inhalation anthrax, the disease usually starts as a brief prodrome resembling a viral respiratory illness. This is followed by development of hypoxia and dyspnea. Victims may initially feel Mild fever, Muscle aches, Malaise, reparatory failure and shock, or meningitis. The most common victims or anthrax is anybody who comes into contact with it. Lately, this disease has been placed in envelopes addressed to random people, and the victim does not notice that they have inhaled the deadly spores. This disease is extremely dangerous and would be very tragic to get it, because it is very hard to cure. The annual number of victims in the United States is approximately 1-2 cases. However, in the fall of 2001, 22 cases of anthrax (11 inhalation, 11 cutaneous) were found in the U.S. Various drugs have been found to be effective in the treatment of anthrax. These drugs include penicillin's, tetracyclines, erythromycins, and other macrolides, chloramphenicol, clindamycin, aminoglycosides, vancomycin, first generation cepahlosporins, and flouroquinolones. Ciprofloxacin is the drug that is most commonly used in the treatment of anthrax.
